DEA schedule

Is Triumeq a controlled substance?

Triumeq contains abacavir, dolutegravir and lamivudine. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Triumeq (abacavir, dolutegravir and lamivudine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abacavir, dolutegravir and lamivudine is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Triumeq?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Triumeq
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances listabacavir, dolutegravir and lamivudine is not on the list

Triumeq NDC listings

NDC listings for Triumeq
NDCProductFormStrengthLabelerDEA schedule
49702-231Triumeqtablet, film coated600 mg/1; 50 mg/1; 300 mg/1ViiV Healthcare CompanyNone

Questions

Is Triumeq a controlled substance?

No. Triumeq (abacavir, dolutegravir and lamivudine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abacavir, dolutegravir and lamivudine is not on the DEA controlled substances list.

Is Triumeq a narcotic?

No. Triumeq (abacavir, dolutegravir and lamivudine) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Triumeq

Try it on your own data today.

Free to start. Most teams are using it the same day.